What is STERIS's stock-based comp?

STERIS (STE) reported stock-based comp of $12.9M in Q1 2026.

How has STERIS's stock-based comp changed year-over-year?

STERIS's stock-based comp increased by 31.6% year-over-year, from $9.8M to $12.9M.

What is the long-term trend for STERIS's stock-based comp?

Over 4 years (2022 to 2026), STERIS's stock-based comp has grown at a 1.7% compound annual growth rate (CAGR), from $57.66M to $61.7M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

STERIS STE Stock-Based Comp

Stock-Based Comp at other companies

Baxter InternationalBAX

$10M0.0%

EcolabECL

$40.3M-4.5%

3MMMM

$41M-6.8%

StrykerSYK

$87M+3.6%

Mesa LaboratoriesMLAB

$6.79M+116%

Boston ScientificBSX

$83M+12.2%

Other financials

Income statement

See full

Revenue$1.6B+7.3%

Gross profit$697.2M+8.8%

Operating income$316.8M+46.6%

Net income$220.2M+51.2%

EPS (diluted)$2.24+52.4%

Balance sheet

See full

Cash & equivalents$439.6M+156%

Total debt$2.1B-10.3%

Total equity$7.2B+8.8%

Total assets$10.7B+5.8%

Cash flow

See full

Operating cash flow$335.4M+28.6%

CapEx$90.2M+27.2%

Free cash flow$245.2M+29.1%

Valuation

See full

Market cap$20.64B-7.5%

Enterprise value$22.28B-7.0%

P/E26.4×-8.1×

P/S3.5×-0.5×

Profitability

See full

Gross margin44.2%+0.2pp

Operating margin18.6%+2.7pp

Net margin13.2%+1.9pp

FCF margin16.4%+2.1pp

Returns & leverage

See full

Return on equity11.3%+1.8pp

Debt / equity0.3×-0.1×

Current ratio2.1×+0.1×

Where this comes from

Reported directly by STERIS in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: STERIS’s 10-K, filed May 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about STERIS's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is STERIS's stock-based comp?: STERIS (STE) reported stock-based comp of $12.9M in Q1 2026.
How has STERIS's stock-based comp changed year-over-year?: STERIS's stock-based comp increased by 31.6% year-over-year, from $9.8M to $12.9M.
What is the long-term trend for STERIS's stock-based comp?: Over 4 years (2022 to 2026), STERIS's stock-based comp has grown at a 1.7% compound annual growth rate (CAGR), from $57.66M to $61.7M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.